Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 7, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	7,181	11,176	4,210	-	-	-
Market Cap Growth	165.44%	165.44%	-	-	-	-
Enterprise Value	8,173	11,861	4,237	-	-	-
Last Close Price	34.25	53.30	20.08	-	-	-
PE Ratio	23.78	36.17	26.16	-	-	-
PS Ratio	0.70	1.09	0.84	-	-	-
PB Ratio	4.60	7.16	4.68	-	-	-
P/TBV Ratio	4.61	7.17	4.68	-	-	-
EV/Sales Ratio	0.80	1.16	0.85	-	-	-
EV/EBITDA Ratio	15.01	21.78	14.29	-	-	-
EV/EBIT Ratio	15.24	22.12	14.55	-	-	-
Debt / Equity Ratio	0.78	0.78	0.83	1.51	0.55	-
Debt / EBITDA Ratio	2.22	2.22	2.52	1.66	0.40	-
Asset Turnover	3.94	3.94	3.91	5.64	10.20	-
Inventory Turnover	5.86	5.86	5.80	6.59	-	-
Quick Ratio	0.35	0.35	0.25	0.14	0.09	4.13
Current Ratio	1.76	1.76	1.92	1.36	1.15	4.13
Return on Equity (ROE)	25.13%	25.13%	31.03%	100.74%	186.74%	-
Return on Assets (ROA)	12.85%	12.85%	14.22%	16.16%	15.73%	-
Return on Capital (ROIC)	15.18%	15.18%	18.26%	39.75%	106.71%	-
Return on Capital Employed (ROCE)	34.30%	34.30%	32.20%	62.10%	96.00%	-
Earnings Yield	4.30%	2.77%	3.82%	-	-	-
FCF Yield	-7.23%	-4.64%	-24.29%	-	-	-
Buyback Yield / Dilution	-18.49%	-18.49%	-55.51%	-4.92%	-301.09%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.